Authors

Arelis Martir-Negron, Baptist Health Medical Group; Miami Cancer InstituteFollow
Yazmin Odia, Baptist Health Medical Group; Miami Cancer InstituteFollow

Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome

Publication Date

8-16-2023

Content Type

Article

PubMed ID:

37585199

Additional Authors:

Additional authors and institutional affiliations

Citation

Sargen, M. R., Kim, J., Potjer, T. P., Velthuizen, M. E., Martir-Negron, A. E., Odia, Y., Helgadottir, H., Hatton, J. N., Haley, J. S., Thone, G., Widemann, B. C., Gross, A. M., Yohe, M. E., Kaplan, R. N., Shern, J. F., Sundby, R. T., Astiazaran-Symonds, E., Yang, X. R., Carey, D. J., Tucker, M. A., … Goldstein, A. M. (2023). Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome. JAMA dermatology, 159(10), 1112–1118. https://doi.org/10.1001/jamadermatol.2023.2621